Three Motley Fool contributors offer second opinions on stocks that are attracting smart money.
News & Analysis: Rhythm Pharmaceuticals Inc
The biopharma stock is bouncing back after the announcement of a share offering.
Investors were excited about the initial public offering of this obesity-drug biotech.
On another record day for Wall Street, Constellation Brands rose on earnings and a biotech IPO almost doubled.